Trial Profile
A Randomized, Placebo- And Positive-Controlled Cross-Over Study To Evaluate The Effect Of Tafamidis On The QTC Interval In Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Oct 2015
Price :
$35
*
At a glance
- Drugs Tafamidis meglumine (Primary) ; Moxifloxacin
- Indications Bacterial infections; Cardiomyopathies
- Focus Pharmacodynamics
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Feb 2013 New trial record